Skip to main navigation Skip to search Skip to main content

Influence of diabetes mellitus on inappropriate and appropriate implantable cardioverter-defibrillator therapy and mortality in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT) Trial

Martin H Ruwald, Wojciech Zareba, Christian Jons, Claire Zhang, Anne-Christine H Ruwald, Brian Olshansky, Scott McNitt, Poul Erik Bloch Thomsen, Morio Shoda, Bela Merkely, Arthur J Moss, Valentina Kutyifa

    28 Citations (Scopus)

    Abstract

    The relationship between diabetes mellitus and risk of inappropriate or appropriate therapy in patients receiving an implantable cardioverter-defibrillator (ICD) and resynchronization therapy has not been investigated thoroughly. The effect of innovative ICD programming on therapy delivery in these patients is unknown.
    Original languageEnglish
    JournalCirculation (Baltimore)
    Volume128
    Issue number7
    Pages (from-to)694-701
    Number of pages8
    ISSN0009-7322
    DOIs
    Publication statusPublished - 13 Aug 2013

    Keywords

    • Aged
    • Algorithms
    • Arrhythmias, Cardiac
    • Cardiac Resynchronization Therapy
    • Cardiac Resynchronization Therapy Devices
    • Defibrillators, Implantable
    • Diabetes Complications
    • Electric Countershock
    • Equipment Failure
    • Female
    • Follow-Up Studies
    • Humans
    • Kaplan-Meier Estimate
    • Male
    • Middle Aged
    • Models, Cardiovascular
    • Proportional Hazards Models
    • Risk
    • Single-Blind Method
    • Tachycardia, Ventricular
    • Unnecessary Procedures

    Fingerprint

    Dive into the research topics of 'Influence of diabetes mellitus on inappropriate and appropriate implantable cardioverter-defibrillator therapy and mortality in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT) Trial'. Together they form a unique fingerprint.

    Cite this